Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
EMBO Molecular Medicine · 11.04.2023 · 15 (4)
DOI: 10.15252/emmm.202216863 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 13.02.2023. Verfasst von Lara Planas-Paz und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Systems Pathology and Functional Tumor Pathology, Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Sarcoma, Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Olga Mayenfisch Stiftung (Olga Mayenfisch Foundation), Swiss Cancer Foundation (SCF), University Hospital Zurich.
Abstract (Originalsprache)
Defects in homologous recombination repair (HRR) in tumors correlate with poor prognosis and metastases development. Determining HRR deficiency (HRD) is of major clinical relevance as it is associated with therapeutic vulnerabilities and remains poorly investigated in sarcoma. Here, we show that specific sarcoma entities exhibit high levels of genomic instability signatures and molecular alterations in HRR genes, while harboring a complex pattern of chromosomal instability. Furthermore, sarcomas carrying HRD ness traits exhibit a distinct SARC‐HRD transcriptional signature that predicts PARP inhibitor sensitivity in patient‐derived sarcoma cells. Concomitantly, HRD high sarcoma cells lack RAD51 nuclear foci formation upon DNA damage, further evidencing defects in HRR. We further identify the WEE1 kinase as a therapeutic vulnerability for sarcomas with HRD ness and demonstrate the clinical benefit of combining DNA damaging agents and inhibitors of DNA repair pathways ex vivo and in the clinic. In summary, we provide a personalized oncological approach to treat sarcoma patients successfully.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Systems Pathology and Functional Tumor Pathology, Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Molecular Tumor Profiling Laboratory, Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Medical Oncology and Haematology, University Hospital Zurich, Zurich, Switzerland.
- Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
- Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Precision Oncology Laboratory, Department for Biomedical Research, Bern Center for Precision Medicine, Bern, Switzerland.
ORCID-Profile: Lara Planas-Paz, Alicia Pliego-Mendieta, Catherine Hagedorn, Domingo Aguilera-Garcia, Martina Haberecker, Fabian Arnold, Marius Herzog, Lorenz Bankel, Roman Guggenberger, Abdullah Kahraman, Martin Zoche, Holger Moch, Christian Britschgi, Chantal Pauli
Förderung
- Olga Mayenfisch Stiftung (Olga Mayenfisch Foundation)
- Swiss Cancer Foundation (SCF)
- University Hospital Zurich
Zitieren
APA
Planas-Paz, L., Pliego-Mendieta, A., Hagedorn, C., Aguilera-Garcia, D., Haberecker, M., Arnold, F., Herzog, M., Bankel, L., Guggenberger, R., Steiner, S., Chen, Y., Kahraman, A., Zoche, M., Rubin, M. A., Moch, H., Britschgi, C., & Pauli, C. (2023). Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. EMBO Molecular Medicine, 15(4). https://doi.org/10.15252/emmm.202216863
Vancouver
Planas-Paz L, Pliego-Mendieta A, Hagedorn C, Aguilera-Garcia D, Haberecker M, Arnold F, et al. Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma. EMBO Molecular Medicine. 2023;15(4). doi:10.15252/emmm.202216863
BibTeX
@article{PlanasPaz2023,
author = {Planas-Paz, Lara and Pliego-Mendieta, Alicia and Hagedorn, Catherine and Aguilera-Garcia, Domingo and Haberecker, Martina and Arnold, Fabian and Herzog, Marius and Bankel, Lorenz and Guggenberger, Roman and Steiner, Sabrina and Chen, Yanjiang and Kahraman, Abdullah and Zoche, Martin and Rubin, Mark A and Moch, Holger and Britschgi, Christian and Pauli, Chantal},
title = {Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma},
journal = {EMBO Molecular Medicine},
year = {2023},
volume = {15},
number = {4},
doi = {10.15252/emmm.202216863}
}
EUVIMED